GWM
FBT icon

Geneos Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Geneos Wealth Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Hold
530
– – ﹤0.01% 1152
2025
Q4 		$109K Hold
530
– – ﹤0.01% 1126
2025
Q3 		$95K Sell
530
-16
-3% -$2.73K ﹤0.01% 1139
2025
Q2 		$88.1K Sell
546
-342
-39% -$54.5K ﹤0.01% 1300
2025
Q1 		$151K Buy
888
+562
+172% +$97.6K ﹤0.01% 1358
2024
Q4 		$54.2K Sell
326
-109
-25% -$18.6K ﹤0.01% 1283
2024
Q3 		$74.8K Hold
435
– – ﹤0.01% 1054
2024
Q2 		$67K Hold
435
– – ﹤0.01% 976
2024
Q1 		$66.9K Sell
435
-73
-14% -$11.1K ﹤0.01% 972
2023
Q4 		$80.3K Hold
508
– – ﹤0.01% 903
2023
Q3 		$74.3K Buy
508
+50
+11% +$7.62K ﹤0.01% 962
2023
Q2 		$70.1K Sell
458
-2
-0.4% -$312 ﹤0.01% 977
2023
Q1 		$71.3K Hold
460
– – ﹤0.01% 958
2022
Q4 		$70.9K Hold
460
– – ﹤0.01% 928
2022
Q3 		$60K Sell
460
-260
-36% -$36.5K ﹤0.01% 966
2022
Q2 		$100K Hold
720
– – ﹤0.01% 1007
2022
Q1 		$107K Sell
720
-428
-37% -$63.3K ﹤0.01% 1062
2021
Q4 		$185K Sell
1,148
-250
-18% -$40.4K 0.01% 903
2021
Q3 		$231K Sell
1,398
-75
-5% -$12.8K 0.01% 803
2021
Q2 		$255K Sell
1,473
-12,712
-90% -$2.1M 0.01% 752
2021
Q1 		$2.33M Buy
14,185
+498
+4% +$85.3K 0.07% 269
2020
Q4 		$264K Buy
13,687
+11,893
+663% +$1.93M 0.01% 733
2020
Q3 		$278K Buy
1,794
+124
+7% +$20.3K 0.01% 578
2020
Q2 		$279K Buy
1,670
+218
+15% +$34.2K 0.02% 566
2020
Q1 		$185K Sell
1,452
-296
-17% -$42.2K 0.01% 637
2019
Q4 		$261K Sell
1,748
-518
-23% -$71.1K 0.01% 597
2019
Q3 		$279K Sell
2,266
-1,307
-37% -$174K 0.02% 551
2019
Q2 		$503K Buy
3,573
+49
+1% +$6.76K 0.03% 401
2019
Q1 		$531K Buy
3,524
+916
+35% +$132K 0.04% 381
2018
Q4 		$316K Buy
2,608
+801
+44% +$110K 0.02% 472
2018
Q3 		$286K Buy
1,807
+185
+11% +$28K 0.02% 527
2018
Q2 		$227K Sell
1,622
-185
-10% -$25.4K 0.02% 536
2018
Q1 		$240K Buy
1,807
+527
+41% +$72K 0.02% 487
2017
Q4 		$159K Sell
1,280
-15
-1% -$1.85K 0.01% 598
2017
Q3 		$160K Sell
1,295
-314
-20% -$37.2K 0.02% 573
2017
Q2 		$183K Sell
1,609
-44
-3% -$4.73K 0.02% 518
2017
Q1 		$174K Buy
1,653
+983
+147% +$98.5K 0.02% 517
2016
Q4 		$60K Buy
670
+202
+43% +$18.9K 0.01% 771
2016
Q3 		$46K Hold
468
– – 0.01% 844
2016
Q2 		$42K Sell
468
-50
-10% -$4.59K 0.01% 864
2016
Q1 		$46K Buy
+518
New +$45.6K 0.01% 817

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Geneos Wealth Management's FBT Position: Q1 2026 in Review

Geneos Wealth Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 530 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1152.

Geneos Wealth Management first reported a position in FBT in Q1 2016 and has held it in 41 quarters since. The position peaked at $2.33M in Q1 2021. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Geneos Wealth Management held 530 shares of First Trust NYSE Arca Biotechnology Index Fund worth $106K as of Q1 2026.
  • Geneos Wealth Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1152 holding.
  • Geneos Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.33M in Q1 2021.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.